NO TITLE

Friday, August 26, 2005 Print

Cambrex serves the innovative and generic pharmaceutical markets; bioresearch, biotherapeutic and biopharmaceutical markets, including universities, research organizations and the government; and a variety of markets for specialty and fine chemicals. The company sells over 2000 products. Most products serve as critical ingredients in the formulation of the customers' products. Approximately, 71% of the Company's revenue is derived from sales to the pharmaceutical or biotech markets.